SULF1 and gastric cancer: Overexpression of Sulf-2 has been shown to inhibit growth of myeloma tumors and breast cancer xenografts (71, 104), and Sulf-1 has been associated with poor prognosis in gastric cancer and lung adenocarcinoma (91, 92).